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Abstract
Background
Multimorbidity–having two or more coexisting chronic conditions–is highly prevalent, costly,
and disabling to older adults. Questions remain regarding chronic diseases accumulation
over time and whether this differs by racial and ethnic background. Answering this knowl-
edge gap, this study identifies differences in rates of chronic disease accumulation and mul-
timorbidity development among non-Hispanic white, non-Hispanic black, and Hispanic
study participants starting in middle-age and followed up to 16 years.
Methods and findings
We analyzed data from the Health and Retirement Study (HRS), a biennial, ongoing, pub-
licly-available, longitudinal nationally-representative study of middle-aged and older adults
in the United States. We assessed the change in chronic disease burden among 8,872 non-
Hispanic black, non-Hispanic white, and Hispanic participants who were 51–55 years of age
at their first interview any time during the study period (1998–2014) and all subsequent fol-
low-up observations until 2014. Multimorbidity was defined as having two or more of seven
somatic chronic diseases: arthritis, cancer, heart disease (myocardial infarction, coronary
heart disease, angina, congestive heart failure, or other heart problems), diabetes, hyper-
tension, lung disease, and stroke. We used negative binomial generalized estimating equa-
tion models to assess the trajectories of multimorbidity burden over time for non-Hispanic
black, non-Hispanic white, and Hispanic participants. In covariate-adjusted models non-His-
panic black respondents had initial chronic disease counts that were 28% higher than non-
Hispanic white respondents (IRR 1.279, 95% CI 1.201, 1.361), while Hispanic respondents
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had initial chronic disease counts that were 15% lower than non-Hispanic white respondents
(IRR 0.852, 95% CI 0.775, 0.938). Non-Hispanic black respondents had rates of chronic dis-
ease accumulation that were 1.1% slower than non-Hispanic whites (IRR 0.989, 95% CI
0.981, 0.998) and Hispanic respondents had rates of chronic disease accumulation that
were 1.5% faster than non-Hispanic white respondents (IRR 1.015, 95% CI 1.002, 1.028).
Using marginal effects commands, this translates to predicted values of chronic disease for
white respondents who begin the study period with 0.98 chronic diseases and end with 2.8
chronic diseases; black respondents who begin the study period with 1.3 chronic diseases
and end with 3.3 chronic diseases; and Hispanic respondents who begin the study period
with 0.84 chronic diseases and end with 2.7 chronic diseases.
Conclusions
Middle-aged non-Hispanic black adults start at a higher level of chronic disease burden and
develop multimorbidity at an earlier age, on average, than their non-Hispanic white counter-
parts. Hispanics, on the other hand, accumulate chronic disease at a faster rate relative to
non-Hispanic white adults. Our findings have important implications for improving primary
and secondary chronic disease prevention efforts among non-Hispanic black and Hispanic
Americans to stave off greater multimorbidity-related health impacts.
Introduction
Multimorbidity, defined as two or more co-occurring chronic diseases, is common in old age,
highly disabling, and costly [1–3]. A growing body of work corroborates the compounding
effects of multimorbidity on health outcomes beyond the risk attributable to individual dis-
eases [4,5] and identifies specific racial and ethnic groups who are at greater risk of poor out-
comes [6–8]. However, few studies have documented the onset and progression of
multimorbidity for various population subgroups over time. Indeed, the U.S. Department of
Health and Human Services reported on remaining gaps in clinical and research practice and
highlighting the need to identify and understand disparities related to race and ethnicity
[9,10].
Whereas the last 50 years has resulted in important longevity gains for older adults in the U.
S. these improvements have not been universal. Slowed and even worsening trends for the
most vulnerable older adults are evident, a regrettable and distinct trend that stands in contrast
to other high-income countries [11]. Indeed, older at-risk adults—among them women,
underrepresented racial and ethnic minorities, and adults with low educational attainment or
low socioeconomic status—are living for extended periods of their lives in sicker and more dis-
abled states and are at greatest risk for premature morbidity and mortality [12,13]. Despite
some evidence that high chronic disease burden disproportionately impacts racial and ethnic
minorities, it is unclear how chronic diseases accumulate differentially in mid- and late-life for
distinct population groups.
Understanding how chronic diseases accumulate over time and develop into multimorbid-
ity among and between adults from various racial and ethnic backgrounds is necessary to bet-
ter plan and deliver care. Groups with earlier onset and/or faster chronic disease accumulation
and multimorbidity development represent prime targets for programs and interventions
aimed at limiting the impact of co-occurring diseases on other outcomes. This is particularly
Racial/ethnic differences in multimorbidity development and accumulation for middle-aged adults
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relevant for racial and ethnic minority adults, who have lower rates of insurance coverage
prior to reaching Medicare eligibility age [14,15] and also have lower rates of utilization of pre-
ventive and diagnostic services even after becoming eligible for Medicare coverage [16,17],
suggesting a higher burden of unmet morbidity needs in these populations.
This study represents a logical continuation of our earlier work [6]. In order to better
understand the process of developing multimorbidity and the accumulation of chronic disease
burden over time, we undertook the present analysis, which focuses on the earliest age in
which we observe study participants and follow these participants over all available time
points. To this end, the aim of this study is to evaluate how multimorbidity develops and pro-
gresses over time among middle-aged non-Hispanic black, non-Hispanic white, and Hispanic
Americans. Ensuring that treatment guidelines and disease management programs address the
impact of multimorbidity on the most complex and vulnerable patients represents a challenge
and a charge to healthcare systems worldwide.
Methods
Data
The Health and Retirement Study (HRS) is a nationally-representative, longitudinal cohort
study of non-institutionalized middle- and older-aged adults which explores the transitions in
health that occur toward the end of a person’s work life and into retirement and permit a wide
array of investigations involving sociodemographic factors as well as patient-reported out-
comes that are generalizable to the U.S. population of middle-aged and older adults [18]. The
HRS is supported by the National Institute on Aging and the Social Security Administration
and as such, represents an important source of publicly-available data for health-related
research. Respondents and their partners are assessed every two years from the time of their
entry into the survey until death. The initial HRS cohort was surveyed in 1992, with additional
cohorts added in 1993, 1998 and every six years onward to refresh the sample and ensure
ongoing sample representativeness [19]. The present study utilized all available biennial assess-
ments for birth cohorts between 1998 through 2014, the most recent finalized data collection
available to date [20].
Study population
This study followed participants over time at the earliest study-entry eligible age for the longest
time possible and with consistent chronic disease burden reporting. This approach maximized
our ability to capture chronic disease accumulation and multimorbidity onset over an
extended period. The study sample was restricted to respondents whose first interview
occurred between the ages of 51 and 55 years old. 31,501 HRS respondents were interviewed
between 1998 and 2014, were living in the community, and were age eligible for the study (i.e.,
respondents with a positive survey weight). Of these respondents, 10,126 were first interviewed
at age 51–55 years old. Consistent with prior publications [21], 844 respondents with clini-
cally-inconsistent self-reporting of chronic disease were excluded (demographic characteristics
for these excluded respondents are reported in the Table B in S1 Appendix); 33 respondents
with missing responses across all chronic conditions at their first age-eligible interview were
excluded; and 8 respondents without race/ethnicity information were excluded. Additionally,
we excluded 369 respondents that identified as American Indian, Asian or “Other” due to
small and heterogeneous racial and ethnic categories that would have insufficient statistical
power to analyze and interpret. Finally, 541 respondents with intermittent participation (i.e.,
respondents with missing interviews in the middle of their follow-up period) were excluded
because of the modeling strategy. The final analytic sample consisted of 8,331 respondents.
Racial/ethnic differences in multimorbidity development and accumulation for middle-aged adults
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Variables
Dependent variable: Chronic disease burden. The main outcome variable in this study
was the count of chronic diseases (range: 0–7). We included all available self-reported chronic
somatic diseases queried in the HRS data, each prompted by “Has a doctor ever told you that
you have. . .”: heart disease (including myocardial infarction, coronary heart disease, angina,
congestive heart failure, or other heart problems), hypertension, stroke (excluding transient
ischemic attack), diabetes, arthritis, lung disease (including chronic bronchitis or emphysema
and excluding asthma), and cancer (including any malignant tumors with the exception of
skin cancer).
We draw from the conceptual framework of multimorbidity that highlights the persistent,
incurable, and chronic nature of disease accumulation and postulates that once a respondent
has developed a disease, the respondent continues to have the disease even if the disease symp-
toms are attenuated through lifestyle changes or medication [22]. Clinically-inconsistencies
disease response patterns exist in the self-report of chronic diseases across HRS waves (i.e.,
affirmative followed by negative responses) and are contrary to this conceptual framework. In
order to address these inconsistencies, we applied a previously developed multistep adjudica-
tion method to our study sample’s responses [21]; briefly, discrepancies were resolved using
disease-specific follow-up questions, which we considered indicative of disease status. Respon-
dents with unresolved inconsistencies of conflicting chronic disease reports were excluded
from the analysis (n = 844, 8.3%).
Key independent variable: Race/ethnicity. Race/ethnicity was defined using the two fol-
lowing questions: 1) “Do you consider yourself Hispanic or Latino?” and 2) “Do you consider
yourself primarily white or Caucasian, Black or African American, American Indian, or Asian,
or something else?” Three mutually-exclusive groups were used in the analyses: non-Hispanic
white (hereafter white), non-Hispanic black (hereafter black), and Hispanic.
Covariates. Sociodemographic covariates included gender (male/female) and education
(number of school years completed). Body-mass index (BMI) was calculated according to the
established formula (BMI = weight [pounds] x 703 / height^2 [inches]) using respondents’
first self-reported height (HRS does not record height at each interview) and self-reported
weight at each interview.
Statistical analysis
Full and complete details of our methodological procedures are provided in the S1 Appendix.
All analyses were conducted in STATA/SE 15 (StataCorp, College Station, TX), while figures
were generated in RStudio version 1.1.456. The HRS over-samples black and Hispanic Ameri-
cans, as well as older residents from Florida. Thus, we present weighted analyses to account for
the oversampling as recommended by the HRS study [23]. Briefly, descriptive methods were
used to summarize characteristics of our study population; frequencies and percentages were
calculated for categorical variables while means and standard deviations or medians and inter-
quartile ranges (IQR) were calculated for continuous variables. In order to assess the relation-
ship between chronic disease accumulation and race/ethnicity, we estimated a series of
negative binomial generalized estimating equation (GEE) models with a first-order autoregres-
sive covariance structure. These models allowed us to estimate the accumulation of chronic
diseases as individuals age, while accounting for the non-independence of observations for an
individual over time. The negative binomial regression was chosen to account for over-disper-
sion (most respondents had no chronic conditions at baseline), assessed with Pearson’s chi-
squared dispersion statistic, and chosen over alternate models based on fit assessed by compar-
ing Bayesian Information Criterion (BIC) values [24,25]. We explored linear, quadratic, and
Racial/ethnic differences in multimorbidity development and accumulation for middle-aged adults
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cubic time terms in all models and determined the linear specification resulted in the best fit.
Variance adjustments for the complex sampling design are not available for negative binomial
GEE analyses in STATA/SE 15.
To control for the influence of loss to follow-up due to mortality and other attrition, we esti-
mated models weighted by inverse probability weights (IPW) for missingness [26]. We
account for differential loss to follow-up because of extensively documented racial and ethnic
disparities in mortality [27,28]. Additional analyses comparing the inclusion and exclusion of
decedents (not shown) demonstrated equivalent findings and provided support for the use of
trimmed IPW weights to account for missingness regardless of the specific reason for loss to
follow-up (i.e., death or attrition). Our final logistic model for missingness included chronic
disease diagnoses, sociodemographic covariates, lifestyle, healthcare utilization, and health sta-
tus variables (full list of model predictors in Tables J-L in S1 Appendix). We subsequently
trimmed the IPWs to achieve a more balanced distribution of the weights [29], where respon-
dents with IPWs�98th percentile of the distribution were removed from the analysis (n = 141
or 0.01% of the sample; Table Q in S1 Appendix compares trimmed and untrimmed models
to guide decision making for this approach).
Model 0 comprised the unconditional GEE model and reports the averaged chronic disease
accumulation for all respondents over time. Model 1 comprised the base GEE model weighted
by trimmed IPWs, and included coefficients for race/ethnicity, time and a race/ethnicity by
time interaction. The interaction term tests for differences in accumulation of chronic diseases
(difference in slope) according to race/ethnicity. Model 2 represents the covariate-adjusted
GEE model weighted by trimmed IPWs. Covariates included time-invariant sociodemo-
graphic factors (race/ethnicity, education, female gender), while BMI was treated as time-
varying.
We present the unexponentiated model coefficients (log odds), the exponentiated model
coefficients or incident rate ratios (IRR), and the predicted values of chronic disease from
model post-estimation commands (Stata procedure margins and lincom, respectively). The
post-estimation predicted values reflect the marginal effect of race/ethnicity on the baseline
count of chronic conditions and the estimated effect of time on the accumulation of chronic
disease calculated at the mean value of covariates, where applicable. Finally, we conducted sen-
sitivity analyses to explore the potential contribution of including net worth (i.e., income and
assets after accounting for outstanding debts) to the covariate-adjusted model and tested
three-way interactions between time, race/ethnicity, and BMI as well as between time, race/
ethnicity, and gender.
Results
The analytic study sample (Table 1) consisted of 8,331 participants, with a mean age at first
interview of 53 years (SD = 1.4) and a mean age at last interview of 61 years (SD = 5.1). Fifty-
seven percent of participants were female, 64% were white, 21% were black, and 15% were His-
panic. Table 2 presents the negative binomial GEE models that specify baseline levels (inter-
cept) and changes in chronic disease accumulation (slope) over the study period. Model 0
specifies a positive slope, indicating an increase in chronic disease accumulation over time for
all study respondents (IRR 1.139, 95% CI, 1.35, 1.143). Model 1 reports the race/ethnicity
adjusted model and indicates black respondents have initial chronic disease counts that are
approximately 40% higher than white respondents (IRR 1.395, 95% CI 1.335, 1.443). With
respect to the slope, black respondents have rates of accumulation that are approximately 1.3%
slower than white respondents (IRR 0.987, 95% CI 0.978, 0.995) and Hispanic respondents
have rates of chronic disease accumulation that are approximately 1.6% faster than white
Racial/ethnic differences in multimorbidity development and accumulation for middle-aged adults
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respondents (IRR 1.016, 95% CI 1.004, 1.029). Model 2 presents the covariate-adjusted results,
and indicates black respondents have baseline chronic disease counts that are approximately
28% higher than white respondents (IRR 1.279, 95% CI 1.201, 1.361), Hispanic respondents
have baseline chronic disease counts that are approximately15% lower than white respondents
(IRR 0.852, 95% CI 0.775, 0.938). Black respondents have rates of chronic disease accumula-
tion that are approximately 1.1% slower than white respondents (IRR 0.989, 95% CI 0.981,
0.998) and Hispanic respondents have rates of chronic disease accumulation that are approxi-
mately 1.5% faster than white respondents (IRR 1.015, 95% CI 1.002, 1.028). In addition,
greater educational attainment is significantly associated with slower accumulations of chronic
disease (IRR 0.956, 95% CI 0.938, 0.953), women have significantly greater accumulations of
chronic disease relative to men (IRR 1.047, 95% CI 1.00, 1.092), and higher BMI is significantly
associated with greater accumulations of chronic disease (IRR 1.011, 95% CI 1.009, 1.013).
Table 3 presents the post-estimation predicted values of chronic disease across models and
reported at the first time period, or ages 51–55, and at the last time period, or ages 69–71 (pre-
dicted values across all time periods reported in Table S in S1 Appendix). On average, study
participants start with 1.03 chronic diseases and end with 2.91 chronic diseases according to
the unadjusted model (Model 0). According to Model 2 estimates, white respondents start
with 0.98 chronic diseases and end with 2.8 chronic diseases; black respondents start with 1.3
chronic diseases and end with 3.3 chronic diseases; and Hispanic respondents start with 0.84
chronic diseases and end with 2.7 chronic diseases.
Fig 1 graphically presents findings from the covariate-adjusted model (Model 3) to visualize
the trajectories of chronic disease accumulation for white, black, and Hispanic respondents.
The horizontal line represents the multimorbidity threshold of having two or more chronic
diseases. Black respondents had significantly higher baseline levels of chronic disease com-
pared to white respondents and exhibit a decreasing rate of chronic disease accumulation rela-
tive to white respondents. In addition, on average, black respondents cross the multimorbidity
threshold approximately four years earlier than white respondents. In contrast, initial levels of
chronic disease were significantly lower for Hispanic relative to white respondents, but the
rate of chronic disease accumulation is significantly greater for Hispanic relative to white
respondents over the study period.
In sensitivity analyses, the addition of net worth into the covariate-adjusted model did not
result in statistically significant findings for net worth nor did this addition change the esti-
mates of other models parameters. Finally, in testing three-way interactions between time,
Table 1. Descriptive characteristics of the study population, HRS 1998–2014.
Characteristic Overall Non-Hispanic White Non-Hispanic Black Hispanic
N 8331 (100) 5341 (64.1%) 1775 (21.3%) 1215 (14.6%)
Ever proxy interview 299 (3.6%) 208 (3.9%) 45 (2.5%) 46 (3.8%)
Age at first interview, mean (SD) 53.0 (1.4) 53.0 (1.4) 53.0 (1.4) 53.1 (1.4)
Age at last interview, mean (SD) 61.0 (5.1) 61.7 (5.1) 59.8 (4.8) 59.7 (4.5)
Gender, female 4759 (57.1%) 2981 (55.8%) 1104 (62.2%) 674 (55.5%)
Education level, median (IQR) 13 (12, 16) 14 (12, 16) 12 (12, 14) 12 (6, 14)
BMI at 1st interview, mean (SD) 29.0 (6.3) 28.3 (6.0) 30.9 (7.1) 29.5 (6.0)
Count of conditions at 1st interview, mean (SD) 1.06 (1.10) 0.98 (1.05) 1.37 (1.20) 1.00 (1.08)
Number of interviews, mean (SD) 4.9 (2.4) 5.3 (2.4) 4.4 (2.2) 4.3 (2.0)
Follow-up
Deceased 511 (6.1%) 323 (6.1%) 136 (7.7%) 52 (4.3%)
Loss to follow-up 1476 (17.8%) 972 (18.2%) 285 (16.1%) 219 (18.0%)
https://doi.org/10.1371/journal.pone.0218462.t001
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Table 2. Negative binomial GEE models of chronic disease accumulation over time, HRS 1998–20141-2.
Model 03 Model 14 Model 25
β (95% CI) IRR (95% CI) β (95% CI) IRR (95% CI) β (95% CI) IRR (95% CI)
Baseline count of chronic
diseases6-7
Overall 0.026 (-0.000,
0.052)
1.026 (1.000,
1.053)
- - - -
White - - ref ref ref ref
Black - - 0.333 (0.270,
0.396)
1.395 (1.310,
1.485)
0.246 (0.184,
0.308)
1.279 (1.201,
1.361)
Hispanic - - 0.012 (-0.074,
0.097)
1.012 (0.929,
1.101)
-0.160 (-0.255,
-0.064)
0.852 (0.775,
0.938)
Accumulation of chronic
diseases8
Time 0.130 (0.127,
0.134)
1.139 (1.35,
1.143)
- - - -
White�Time - - ref ref ref ref
Black�Time - - -0.013 (-0.022,
-0.005)
0.987 (0.978,
0.995)
-0.011 (-0.020,
-0.002)
0.989 (0.981,
0.998)
Hispanic�
Time
- - 0.016 (0.004,
0.029)
1.016 (1.004,
1.029)
0.015 (0.002,
0.027)
1.015 (1.002,
1.028)
Covariates Education - - - - -0.056 (-0.064,
-0.048)
0.956 (0.938,
0.953)
Female - - - - 0.046 (0.003,
0.088)
1.047 (1.00,
1.092)
BMI - - - - 0.011 (0.009,
0.013)
1.011 (1.009,
1.013)
Abbreviations: GEE = generalized estimating equations; HRS = Health and Retirement Study; IRR = incidence rate ratios; CI = confidence interval; BMI = body mass
index.
1 Models were constructed to compare Non-Hispanic Black and Hispanic respondents to Non-Hispanic White respondents (reference group); bolded estimates are
statistically significant at the p<0.05 alpha-level.
2 Results are presented as estimated model coefficients (β) and exponentiated β-coefficients or incident rate ratios (IRR).
3 Model 0—unconditional GEE model.
4 Model 1—GEE model weighted by IPW�baseline HRS respondent weights.
5 Model 2—GEE model weighted by IPW�baseline HRS respondent weights and adjusted for education, gender, and time-varying BMI.
6 Baseline count of chronic diseases (intercept), Model 0 interpretation: β-coefficient is the difference in log(count) of chronic conditions; IRR is the proportional
difference in baseline chronic disease count relative to the counterfactual.
7 Baseline count of chronic diseases (intercept), Models 1 & 2 interpretation: β-coefficients are the difference in log(count) of chronic conditions relative to Non-
Hispanic white respondents at baseline; IRRs are the proportional difference in baseline chronic disease count relative to Non-Hispanic white respondents and can be
interpreted as “Non-Hispanic black respondents had a baseline count of chronic diseases 1.395 times higher than Non-Hispanic white respondents.”
8 Accumulation of chronic diseases (slope): IRR is the proportional difference in accumulation of chronic disease relative to Non-Hispanic white respondents. This can
be interpreted as “Non-Hispanic black respondents accumulate chronic disease at a rate 0.987 times slower than Non-Hispanic white respondents.”
https://doi.org/10.1371/journal.pone.0218462.t002
Table 3. Predicted values for chronic disease accumulation over time, HRS 1998–20141,2.
Model 0 Model 1 Model 2
Time period Overall Non-Hispanic White Non-Hispanic Black Hispanic Non-Hispanic White Non-Hispanic Black Hispanic
First (age 51–55) 1.026 (0.014) 0.982 (0.016) 1.370 (0.038) 0.994 (0.040) 0.983 (0.016) 1.258 (0.034) 0.838 (0.038)
Last (age 69–71) 2.908 (0.032) 2.797 (0.037) 3.509 (0.082) 3.223 (0.109) 2.811 (0.038) 3.295 (0.083) 2.695 (0.105)
Abbreviations: HRS = Health and Retirement Study.
1Results are presented as predicted values derived from post-estimation marginal effects for the baseline count of chronic conditions and linear combinations of
coefficients for the accumulation of chronic diseases calculated at the mean of covariate values in the covariate-adjusted model.
2Standard errors reported in parentheses.
https://doi.org/10.1371/journal.pone.0218462.t003
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race/ethnicity, and BMI as well as between time, race/ethnicity, and gender across all model
specifications, none of these interactions were statistically significant. Sensitivity analyses
results are not presented but are available upon request.
Discussion
This study assessed the accumulation of chronic disease and traced the progression of multi-
morbidity over a 16-year period among a middle-aged nationally-representative population in
the United States. We sought to specify chronic disease accumulation and multimorbidity pro-
gression at the earliest age we observe HRS respondents—from their early to mid-50s to the
most recent finalized data collection. As a result, our study adds to the multimorbidity
Fig 1. Non-Hispanic black, Non-Hispanic white, and Hispanic trajectories of chronic disease accumulation over time, HRS 1998–2014.
https://doi.org/10.1371/journal.pone.0218462.g001
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literature by specifying changes in chronic disease accumulation and tracking differences in
multimorbidity development for a diverse group of adults starting in middle-age. Several
aspects of our findings are noteworthy. While it is unsurprising that middle-aged adults in the
U.S. are accumulating chronic disease over time, black middle-aged adults had significantly
higher initial levels of chronic disease burden compared with white counterparts. On average,
black middle-aged adults crossed the multimorbidity threshold approximately four years prior
to white middle-aged adults—mid-to-late 50s compared to early-to-mid 60s. Notably, His-
panic middle-aged adults accumulate disease at a faster rate than white middle-aged study par-
ticipants. In combination, these findings suggest differential opportunities for preventing and
reducing racial/ethnic disparities in multimorbidity—prior to entering middle age to delay the
onset and lower the initial burden of chronic diseases among black adults, while focusing on
preventing or slowing the accumulation of diseases in older age (late 60s and 70s) in the His-
panic population.
Our study complements findings from several prior studies [30–32] by addressing impor-
tant gaps in our knowledge regarding the longitudinal development and progression of multi-
morbidity [33]. Similar to our findings, a study of multimorbidity incidence in a defined
geographic region in the United States found that black adults were at greater risk of high dis-
ease burden and earlier multimorbidity onset [31]. However, in contrast to our prior study
that examined racial and ethnic differences in chronic disease trajectories and found near-
identical time trends between white and Mexican Americans [6], we found differences in the
rate of change in chronic disease accumulation among Hispanic Americans. It is likely we
observe a more rapid accumulation of chronic disease among Hispanics because our current
study focuses on adults starting in their early to mid-50s, a susceptible period for age-related
chronic diseases such as metabolic conditions that are more prevalent among Hispanic popu-
lations [34,35]. Our results highlight the importance of estimating multimorbidity trajectories
starting in mid-life and make a case for preventing age-related chronic disease earlier in the
lifecourse for at-risk populations.
Earlier lifecourse development of chronic disease and multimorbidity among non-Hispanic
black Americans may indicate earlier and longer cumulative exposure to risk factors common
to many of the chronic diseases that comprise multimorbidity. Risk factors that assault multi-
ple body systems are prevalent among racial and ethnic minority populations in the U.S.—for
example, obesity, chronically elevated stress levels, or elevated systemic inflammatory markers
—and may, in turn, lead to earlier multimorbidity development [36–38]. In addition, poor
access to good quality health care and low socioeconomic status may exacerbate and accelerate
additional chronic disease development [39]. For example, Hispanic adults have greater preva-
lence of obesity and greater risk of developing diabetes in midlife [34]. If left uncontrolled or
poorly controlled, these populations may be at risk of developing harbinger conditions—such
as hypertension—that may be precursors for resulting complications, events, or additional
diagnoses—such as myocardial infarction and stroke. A cascade of chronic disease following
an influential diagnosis may account for the more rapid accumulation of chronic disease
observed among Hispanic groups in this study.
Further, several publications across a range of international settings largely agree with our
main results, finding greater accumulation of chronic disease and multimorbidity with older
age and among groups with particular social or behavioral vulnerabilities [30–32]. A clinical
study sample in the Netherlands reported that a small group (~5%) of patients seen in family
practice clinics account for a large (>20%) proportion of reported chronic diseases, due to
“intensive” multimorbidity patterns of 10 or more diseases accumulated over the lifecourse,
and called for identifying factors associated with increased vulnerability in this group [30].
Similarly, a study examining multimorbidity trends in a nationally-representative sample of
Racial/ethnic differences in multimorbidity development and accumulation for middle-aged adults
PLOS ONE | https://doi.org/10.1371/journal.pone.0218462 June 17, 2019 9 / 13
Canadians reported earlier onset of multimorbidity in mid-life in recent cohorts and among
obese adults and among low-income groups [32]. It is notable that our study found no associa-
tion with wealth in either the level or rate of chronic disease accumulation, likely due to high
correlation between race/ethnicity, education, and wealth in the United States. Future studies
may need to investigate cohort differences in multimorbidity development across racial/ethnic
groups, to support the development of initiatives and programs to address forthcoming health-
care needs for changing demographic trends among vulnerable groups.
This study has several strengths. First, the HRS provides ongoing, robust longitudinal data
reflecting a wide array of health, sociodemographic, and patient-reported outcomes generaliz-
able to the U.S. population of middle-aged and older adults. These data provide the opportu-
nity to observe changes in participant reports of chronic disease burden and multimorbidity
onset during critical periods of middle to late adulthood in a large, ongoing prospective cohort
study. Second, this study contributes to the emerging literature on the epidemiology of multi-
morbidity by specifying the longitudinal progression of multimorbidity burden over 16 years.
Third, the prospective design and oversampling of racial and ethnic minority populations in
the HRS permits assessment of time-sequencing of chronic disease burden and accumulation,
and enables the estimation of multimorbidity onset and progression between adults from vari-
ous racial and ethnic backgrounds. Fourth, by accounting for differences in mortality and loss
to follow-up, our study provides important insights into differential rates of chronic disease
accumulation between racial and ethnic groups, an improvement over prior work. In these
ways, our study contributes to the evolving literature on multimorbidity and provides key
insights into the examination of multimorbidity from a longitudinal perspective.
We also note several limitations to this study. First, we used a limited number of chronic
diseases available in the public-use data files of the HRS. Future steps include leveraging the
Medicare-HRS data linkage to ascertain a greater number of diagnoses, specifically, the 20
chronic diseases recommended by the U.S. Department of Health and Human Services for the
operationalization of multimorbidity: diseases associated with aging that are persistent, preva-
lent, and incurable [9,22]. Second, chronic disease diagnoses were self-reported, which may
reflect underreporting or underdiagnosis of chronic disease, particularly for adults with low
health literacy, or those who experience lack of access to a usual source of care. Still, for adults
with healthcare access, several studies have shown adequate concordance between patient
reports of various physician-diagnosed chronic diseases and administrative or clinical data
sources [40–42], and many studies highlight the importance of documenting patient reported
outcomes of disease status [43–45]. Third, because of the limited number of American Indians,
Asians and those who identified as “other” we did not have sufficient power to include them in
the models. These are vulnerable population which should be studied. Fourth, these observa-
tional survey data provide associations and do not imply causation. Finally, standard error
adjustments were not available for the analyses conducted, however small p-values suggest
there would be few differences in the overall conclusions had adjustments been possible.
While our study centers on quantifying and identifying trends in chronic disease accumula-
tion and multimorbidity development over time, we see these examinations as a first step in a
progression of important research questions. We were unable to ascertain the severity of
chronic disease and multimorbidity burdens with these data. Future research is needed to
investigate the role of clinical presentation and severity of component diseases or prognosis, as
well as the association between multimorbidity progression and outcomes important for older
adults, such as functional disability, dementia, frailty, and other geriatric syndromes. Further,
we did not examine preventive healthcare services that may be related to accumulation of
chronic conditions. Lastly, our study did not focus on the mechanisms or underlying reasons
for observed differences in multimorbidity and chronic disease accumulation. Further
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research is needed to more carefully examine the joint processes of morbidity and mortality
among racially diverse middle and older adults, and to understand whether the higher rate of
accumulation for Hispanics in late mid-life was related to more global health differences or
access to Medicare benefits and improved access to healthcare that may address issues of
underdiagnosis earlier in the lifecourse for this population.
Our study has important clinical and research implications by suggesting that multimorbid-
ity is not only common, but emerging earlier in middle age and progressing more rapidly for
underrepresented racial and ethnic groups in the United States. Our findings raise significant
public health and healthcare system challenges for how best to avert and delay further com-
pounding of clinical complexity among older adults. Specifically, these results highlight the
need for proactive interventions and policies designed to optimize clinical care, preserve func-
tional independence, and delay institutionalization for patients with high multimorbidity bur-
den, particularly those from minority racial and ethnic backgrounds.
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